Ticker Launch

Reverse merger · Completed · LMMY

Exousia Ai, Inc.

Reverse merger with L a M Y

Exousia Ai, Inc. merged into L a M Y, a Wyoming shell-like company formerly in educational services, in a reverse merger that takes the private company public. The deal was announced on Nov 11, 2025 and closed on Nov 17, 2025. The combined company trades as Exousia Bio, Inc. (LMMY) on OTC.

Exousia Bio, Inc. is a clinical-stage biotechnology company developing therapeutic uses of exosomes, initially focused on oncology.

Status
Completed
Private company
Exousia Ai, Inc.
Public company
L a M Y
Public company business before
Wyoming shell-like company formerly in educational services
Announced
Nov 11, 2025
Closed
Nov 17, 2025
Combined company
Exousia Bio, Inc. (LMMY)
Exchange
OTC
Sector
Biotech & pharma

More on this deal for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other completed reverse mergers